Aridis Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$30,749,000 over the previous period. Total operating expenses were $29,993,000.
Profit Margin
| 2016 | 2.26M | -8.42M | -371.18% |
|---|---|---|---|
| 2017 | 860K | -24.65M | -2866.98% |
| 2018 | 2.75M | -22.10M | -801.78% |
| 2019 | 1.02M | -28.98M | -2836.2% |
| 2020 | 1M | -21.91M | -2191.9% |
| 2021 | 0 | -42.28M | |
| 2022 | 0 | -30.74M |
ARDS Income Statement (2016 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|
Revenue | |||||||
Revenue | 0 | 0 | 1M | 1.02M | 2.75M | 860K | 2.26M |
Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 | 1.92M |
Gross profit | 0 | 0 | 1M | 1.02M | 2.75M | 860K | 342K |
Operating exp. | |||||||
Research and development | 25.92M | 37.93M | 16.95M | 24.08M | 23M | 17.43M | 6.26M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 29.99M | 43.71M | 23.40M | 30.10M | 26.87M | 20.59M | 8.22M |
Operating income | -29.99M | -43.71M | -22.40M | -29.08M | -24.11M | -19.73M | -7.88M |
Other income (expenses), net | -378K | 518K | 68K | -594K | 1.59M | -4.91M | -172K |
Income before tax | -30.37M | -43.19M | -22.33M | -29.68M | -22.10M | -24.65M | -8.42M |
Income tax expense | 378K | -912K | -414K | -695K | 2.43M | 4.91M | 538K |
Net income | -30.74M | -42.28M | -21.91M | -28.98M | -22.10M | -24.65M | -8.42M |
Earnings per share | |||||||
Basic EPS | -1.64 | -3.44 | -2.39 | -3.43 | -7.02 | -3.12 | -1.07 |
Diluted EPS | -1.64 | -3.44 | -2.39 | -3.43 | -7.02 | -3.12 | -1.07 |
| Data source | Data source | Data source | Data source | Data source |